Search hospitals > Pennsylvania > Philadelphia
Kimmel Cancer Center at Thomas Jefferson University - Philadelphia
Claim this profilePhiladelphia, Pennsylvania 19107
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Prostate Cancer
Conducts research for Prostatic Neoplasm
Conducts research for Cancer
364 reported clinical trials
36 medical researchers
Summary
Kimmel Cancer Center at Thomas Jefferson University - Philadelphia is a medical facility located in Philadelphia, Pennsylvania. This center is recognized for care of Breast Cancer, Lung Cancer, Prostate Cancer, Prostatic Neoplasm, Cancer and other specialties. Kimmel Cancer Center at Thomas Jefferson University - Philadelphia is involved with conducting 364 clinical trials across 280 conditions. There are 36 research doctors associated with this hospital, such as Sarah W. Gordon, DO, Babar Bashir, Usama Gergis, MD, and Maysa Abu-Khalaf, MD.Area of expertise
1Breast Cancer
Global LeaderStage IV
Stage III
Stage II
2Lung Cancer
Global LeaderStage IV
Stage III
Stage II
Top PIs
Sarah W. Gordon, DOVirginia Commonwealth University/Massey Cancer Center8 years of reported clinical research
Expert in Lung Cancer
Expert in Non-Small Cell Lung Cancer
26 reported clinical trials
54 drugs studied
Babar BashirThomas Jefferson University Hospital1 year of reported clinical research
Studies Cancer
Studies Solid Tumors
14 reported clinical trials
28 drugs studied
Usama Gergis, MDThomas Jefferson University8 years of reported clinical research
Studies Lymphoma
Studies Hematologic Malignancies
13 reported clinical trials
29 drugs studied
Maysa Abu-Khalaf, MDThomas Jefferson University Hospital6 years of reported clinical research
Studies Breast Cancer
Studies Breast cancer
12 reported clinical trials
26 drugs studied
Clinical Trials running at Kimmel Cancer Center at Thomas Jefferson University - Philadelphia
Breast Cancer
Cancer
Pancreatic Cancer
Lung Cancer
Prostate Cancer
Breast cancer
Solid Tumors
Ovarian Cancer
Parotid Gland Cancer
Non-Small Cell Lung Cancer
CLSP-1025
for Cancer
Phase 1 dose escalation and expansion study of CLSP-1025, a first-in-class HLA-A\*02:01 specific T cell engager (TCE) targeting solid tumors that harbor the p53 R175H mutation.
Recruiting1 award Phase 16 criteria
BT8009 + Pembrolizumab
for Solid Tumors
This study is a Phase I/II, multicenter, first-in-human, open-label dose-escalation study of BT8009 given as a single agent and in combination with pembrolizumab in participants with advanced solid tumors associated with Nectin-4 expression or in participants with advanced solid tumor malignancies having renal insufficiency. The primary endpoints are: Dose limiting toxicities (Parts A-1 and A-2), Overall response rate per RECIST v1.1 (Parts B1-B7), Safety and tolerability (Parts B-8, B-9 and C), and characterization of the pharmacokinetics (Part D).
Recruiting1 award Phase 1 & 214 criteria
Time Restricted Eating
for Breast Cancer
This trial studies if intermittent fasting can improve outcomes for breast cancer patients with a BMI of 25 or higher who are receiving chemotherapy. The fasting involves not eating for a certain period and eating during another specific period each day. This approach may help control blood sugar and insulin levels, potentially reducing tumor growth. Intermittent fasting has been studied for its potential benefits in weight loss and managing cardiometabolic risk factors.
Recruiting1 award N/A10 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Kimmel Cancer Center at Thomas Jefferson University - Philadelphia?
Where is Kimmel Cancer Center at Thomas Jefferson University - Philadelphia located?
Who should I call to ask about financial aid or insurance network?
What insurance does Kimmel Cancer Center at Thomas Jefferson University - Philadelphia accept?
What awards or recognition has Kimmel Cancer Center at Thomas Jefferson University - Philadelphia received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.